| abstract |
The present invention discloses oligosaccharide sequences that are specifically expressed by human tumors. The present invention relates to a method for detecting the presence of an oligosaccharide sequence having a tumor-specific terminal N-acetylglucosamine residue in a biological sample and detecting cancer using the presence of the sequence as an index. The present invention provides an antigenic substance containing the oligosaccharide sequence in a multivalent form, and further comprises a diagnostic agent, a pharmaceutical composition and a cancer vaccine comprising the oligosaccharide sequence or a binding substance that binds to the oligosaccharide sequence I will provide a. The present invention also relates to a method for treating cancer. |